nevirapine has been researched along with rolipram in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Buckheit, RW; Cheung, YF; Cullen, MD; Cushman, M; De Clercq, E; Hartman, TL; Houslay, MD; Pannecouque, C; Watson, KM | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Anaclerio, B; Bieza, K; Caldwell, J; Ellis, D; He, X; He, Y; Karanewsky, D; Kuhen, K; Ngoc Nguyen, T; Wolff, K; Wu, B; Yang, K; Yin, H | 1 |
4 other study(ies) available for nevirapine and rolipram
Article | Year |
---|---|
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors.
Topics: Alkenes; Cell Line, Tumor; Cyclic Nucleotide Phosphodiesterases, Type 4; HIV Reverse Transcriptase; Humans; Inhibitory Concentration 50; Methane; Oxazoles; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2008 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Topics: Anti-HIV Agents; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrrolidinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 2006 |